TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AstraZeneca to cut 1,600 in U.S., U.K.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

AZN $46.18 -$0.28

at close on MONDAY

By The Associated Press
Tuesday, March 19, 2013, 12:01 a.m.
 

Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the United States and United Kingdom, as its new CEO starts a major research and development reorganization.

The cuts come just weeks after the company reported big drops in revenue and net income for 2012 and forecast continuing difficulties as generic competition hurts sales.

The job reductions amount to nearly 3 percent of AstraZeneca's 57,200 workers.

worldwide and are part of moves affecting several major AstraZeneca sites in the UK, US and Sweden.

Even the global headquarters will be shifted, from London to Cambridge, England, as the company moves many of its scientists near top centers for bioscience research. Rivals have been doing the same, to be near those talent pools and to increase collaborations with scientists at universities and small biotech companies.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Student loan debt presents paradox
  2. Large-scale batteries are integral in shift to renewable energy
  3. PPG to buy Westmoreland Supply paint store chain
  4. Plastics, tech sectors crucial to cracker plants
  5. Open enrollment puts varied impact of health care law back in focus
  6. Mortgage in reach despite few dings
  7. Energy Spotlight: Steve Anthos
  8. Augmented reality frees gaming from TV
  9. Highmark to increase premiums, limit access to health care in new plans
  10. Questions to ask before renewing coverage
  11. Small businesses plan for profitable winter
Subscribe today! Click here for our subscription offers.